Recurrent MET fusion genes represent a drug target in pediatric glioblastoma. [electronic resource]
Producer: 20170731Description: 1314-1320 p. digitalISSN:- 1546-170X
- Adolescent
- Adult
- Anilides -- pharmacology
- Animals
- Brain Neoplasms -- drug therapy
- Cell Line, Tumor
- Child
- Child, Preschool
- Crizotinib
- DNA, Neoplasm
- Female
- Glioblastoma -- drug therapy
- Humans
- Infant
- Male
- Mice
- Mice, SCID
- Microtubule-Associated Proteins -- genetics
- Mitogen-Activated Protein Kinases
- Oncogene Proteins, Fusion -- genetics
- Protein Kinase Inhibitors -- pharmacology
- Proteins -- genetics
- Proto-Oncogene Proteins c-met -- antagonists & inhibitors
- Pyrazoles -- therapeutic use
- Pyridines -- therapeutic use
- Quinolines -- pharmacology
- RNA, Messenger -- metabolism
- Receptor-Like Protein Tyrosine Phosphatases, Class 5 -- genetics
- Sequence Analysis, DNA
- Signal Transduction
- Xenograft Model Antitumor Assays
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.